Uncategorised - European Medical Journal

Continue
2 Dec 2022

IME Rheumatology Webinar | Key Insights from ACR 2022: An Interdisciplinary Expert Roundtable Discussion

Join us for a roundtable discussion to gain a deeper understanding of emerging data from ACR 2022 and real-world evidence with biosimilars…

Is the pharma rep at death's door?

While technology advances and mindsets shift, will there be space and demand for the role of the pharma sales reps in future?
2 Dec 2022

Could Shingles Increase Risk of Myocardial Infarction and Stroke?

According to new research, varicella zoster, the virus responsible for causing chicken pox and shingles, could increase the risk of coronary heart disease (CHD) and stroke. Read for more.
2 Dec 2022

Does Adding Probiotics to Antibiotic Regimens Reduce Antibiotic-Induced Gut Microbiome Changes?

Using a probiotic alongside antibiotic treatment has been shown to prevent some of the antimicrobial-induced gut microbiome changes associated with antibiotic use, according to the results of a systematic review. Read more.
2 Dec 2022

Influenza Vaccination Beneficial for Patients with Heart Failure

According to new research, influenza vaccination results in a significant decrease in hospitalisations related to heart failure…
2 Dec 2022

When to Exercise to Lower Risk of Heart Disease

Exercising in the morning is associated with the lowest risk of heart disease and stroke. Read to find out more…
2 Dec 2022

Understanding the Economics of Human Health

This episode discusses the role of health economics consultancies and the National Institute for Health and Care Excellence.
1 Dec 2022

Is Sexual Function After Brachytherapy Unaddressed in Female Patients?

According to research, the sexual side effects of cancer treatment are discussed far less frequently with female patients than male patients…
1 Dec 2022

Risk Factors for Conversion from Partial to Radical Nephrectomy

Converting from partial to radical nephrectomy is uncommon, but it can increase the likelihood of an unplanned transition…

Pharma in Japan

The Japanese pharma industry has many intricacies, so how can companies navigate the ups and downs?